CASI PHARMACEUTICALS, INC. (CASIF) Stock buybacks 2024–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$278,000FY2025 · since FY2024: $3.3M → $278,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $278,000 | -91.5% |
| FY2024 | $3.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CASIF financial trends
CASIF RevenueCASIF Net incomeCASIF Net marginCASIF Gross profitCASIF Gross marginCASIF Operating incomeCASIF Operating marginCASIF Operating cash flowCASIF Free cash flowCASIF Capital expendituresCASIF Return on equityCASIF Dividends paidCASIF Total assetsCASIF Total liabilitiesCASIF Shareholders’ equityCASIF overview →